Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes

Lignende værker

• Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes
  af: Cedena, M. Teresa, et al.
  Udgivet: (2017)
• Safety and efficacy of azacitidine in myelodysplastic syndromes
  af: Vigil, Carlos E, et al.
  Udgivet: (2010)
• Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts
  af: Martín, Iván, et al.
  Udgivet: (2017)
• Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia
  af: Palomo, Laura, et al.
  Udgivet: (2019)
• Azacitidine in the management of patients with myelodysplastic syndromes
  af: Khan, Cyrus, et al.
  Udgivet: (2012)